Insecticides (India) Limited (INSECTICID) — Financial Results(5 announcements)
Investor Takeaways
Overall Tone: Cautious
Key Financial Highlights
| Metric | Value | YoY Change |
|---|---|---|
| Revenue | ₹2,931.60 lakhs | N/A |
| Net Profit | ₹(76.03) lakhs | Decline from ₹459.65 lakh profit |
| Cash Flow from Operations | ₹13,633.85 lakhs | Improved from prior year |
| EPS | Not available | N/A |
| OPM | Not available | N/A |
What Changed
The company reversed from a profit of Rs. 459.65 lakh in FY2025 to a net loss of Rs. (76.03) lakhs in FY2026, indicating a significant deterioration in profitability. Despite this, cash flow from operations strengthened to Rs. 13,633.85 lakhs, suggesting improved operational liquidity. The board approved the audited FY2026 results, appointed Sanskar Aggarwal as Whole-Time Director, and accepted Nikunj Aggarwal’s resignation effective May 28, 2026. Additionally, the company dissolved its Dubai subsidiary during the fiscal year, which may have impacted financials. The unmodified auditor's opinion confirms no material reservations in the financial statements.
Peer Comparison
| Company | P/E | ROE | ROCE | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Insecticides (India) Limited | 15.74 | N/A | N/A | 2,103.19 |
| Solar Industries India Limited | 132.27 | N/A | N/A | 1,56,674.48 |
| Pidilite Industries Limited | 75.73 | N/A | N/A | 1,49,378.89 |
| SRF Limited | 69.51 | N/A | N/A | 79,723.46 |
The company trades at a significantly lower P/E ratio compared to peers like Solar Industries, Pidilite, and SRF, suggesting potential undervaluation or lower market expectations. However, peers' ROE and ROCE data are not available for direct comparison.
Risks & Concerns
Quarterly Trend
| Quarter | Revenue (₹ Cr) | Net Profit (₹ Cr) | OPM% |
|---|---|---|---|
| Q3FY25 | 357.7 | 17.36 | 8.64 |
| Q2FY25 | 627.09 | 61.49 | 14.28 |
| Q1FY25 | 656.69 | 49.01 | 10.89 |
| Q4FY24 | 272.5 | 7.76 | 3.28 |
The quarterly trend shows fluctuating profitability, with Q2FY25 delivering the highest profit (₹61.49 Cr) and Q4FY24 the lowest (₹7.76 Cr). OPM declined from 14.28% in Q2FY25 to 3.28% in Q4FY24, indicating margin pressure in the final quarter. The FY2026 net loss appears to be an outlier compared to recent quarterly performance, which showed consistent profits and improving margins in earlier quarters. The annual loss may reflect exceptional items or one-time adjustments not captured in quarterly trends.
The Board approved audited FY2026 financial results showing revenue of ₹4,262.60 crores, profit before tax of ₹3,300.33 crores, and net profit of ₹1,170.99 crores with EPS of [amount not verified]. Cash flow from operations reached ₹10,872.41 crores, while net cash increased by ₹3,174.50 crores after outflows in investing and financing activities. The filing also details management changes including the resignation of Whole-Time Director Nikunj Aggarwal and appointments of Sanskar Aggarwal as Whole-Time Director (Additional) and Atul Kumar as Vice President-Sales (North).
Insecticides (India) Limited reported consolidated revenue of ₹2,140 crores for Q4 FY26, a 19% YoY increase, and ₹2,000 crores for FY26, a 7% YoY rise. Gross profit margin stabilized at 31.5% for FY26 versus 32% in FY25, while EBITDA margin declined to 10.6% in Q4 FY26 from 11.1% in Q4 FY25. The company highlighted new product launches, including Granuvia with Corteva, and strong farmer engagement across 26,000+ meetings.
Insecticides (India) Limited reported FY26 revenue of ₹2,140 crores, up 7% YoY, with gross profit margin expanding to 31.5% and EBITDA margin improving to 10.6%. PAT margin stood at 6.5%, reflecting stable profitability. The company highlighted premiumization driving growth, with premium products contributing 58% of B2C sales. Key financials include revenue of ₹2,140 crores (FY26), gross profit of ₹675 crores, EBITDA of ₹227 crores, and PAT of ₹139 crores. The presentation emphasized robust distribution reach (8,500+ distributors, 75,00,000+ farmers) and strategic R&D investments.
Insecticides (India) Limited announced approval of FY2026 audited financial results and key leadership changes including the appointment of Sanskar Aggarwal as Whole-Time Director and Atul Kumar as Vice President-Sales (North), alongside the resignation of Nikunj Aggarwal effective May 28, 2026. The filing also confirmed the appointment of T Jain & Associates as Internal Auditor and detailed the Employee Stock Purchase Scheme 2026 requiring shareholder approval at the upcoming AGM. The Board approved the financial statements and new appointments during its May 28 meeting, with the AGM scheduled for August 12, 2026, to ratify these changes and the auditor appointments.
About Insecticides (India) Limited (INSECTICID)
Chemicals · Fertilizers & Agrochemicals · Listed on NSE
📡 Get AI alerts when INSECTICID files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track INSECTICID — Free💡 Ask AI about this filing
📊 More INSECTICID filings
- share transfer — 7 July 2026 Insecticides (India) Limited received a SEBI-mandated share transfer agent certificate for the quart...
- Financial Results — 22 June 2026 Insecticides (India) Limited announced that its trading window for designated persons and immediate ...
- Announcement — 5 June 2026 Insecticides (India) Limited announced its upcoming schedule of analyst and institutional investor m...
- 🔴 Financial Results — 3 June 2026 Insecticides (India) Limited reported FY26 revenue of INR2,140 crores, up 7% YoY, with gross profit ...
- Announcement — 16 May 2026 Insecticides (India) Limited announced the launch of GRANUVIA™, a new insecticide targeting brown pl...
🔥 Also filed on 28 May 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when INSECTICID files new disclosures
Track INSECTICID filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track INSECTICID — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research